Publications by authors named "David Escors"

Claim this Profile
P
Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.
David Escors, Luisa Chocarro, Miriam Echaide, Claudia Rodriguez-Neira, Borja Vilaplana

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, David Escors

EMBO Mol Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractalkine in Health and Disease.
Claudia Rodriguez, Luisa Chocarro, Miriam Echaide, Karina Ausin, David Escors

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of myeloid-derived suppressor cell differentiation ex vivo.
Ester Blanco, David Escors, Grazyna Kochan

Methods Cell Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.
Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra, Luisa Chocarro, Antonio Procopio, David Escors

Br J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.
Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja, Irene Hernandez-Garcia, Hugo Arasanz, David Escors

Head Neck· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
Marta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz, Adriá Caballé-Mestres, Verónica Moncho-Amor, David Escors

Nat Metab· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.
Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona, Ester Blanco, Miren Zuazo, David Escors

EMBO Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Bocanegra, David Escors

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, David Escors

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.
Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David Escors

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Bocanegra, Hugo Arasanz, David Escors

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting-Edge CAR Engineering: Beyond T Cells.
Luisa Chocarro, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, Ana Bocanegra, David Escors

Biomedicines· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.
David Escors, Ana Bocanegra, Luisa Chocarro, Ester Blanco, Sergio Piñeiro-Hermida

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.
Miriam Echaide, Ibone Labiano, Marina Delgado, Angela Fernández de Lascoiti, Patricia Ochoa, David Escors

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions.
Mercedes Lachén-Montes, Naroa Mendizuri, Karina Ausín, Miriam Echaide, Ester Blanco, David Escors

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.
Hugo Arasanz, Ana Isabel Bocanegra, Idoia Morilla, Joaquín Fernández-Irigoyen, Maite Martínez-Aguillo, David Escors

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.
Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti, Giulia Accardi, Hugo Arasanz, David Escors

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, Giulia Accardi, Anna Calabrò, David Escors

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor.
Luisa Chocarro, Ana Bocanegra, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, David Escors

Cells· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The multi-specific V-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity.
Carolyn J Edwards, Angelica Sette, Carl Cox, Barbara Di Fiore, Chris Wyre, David Escors

Br J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy.
Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Ibarra Zuazo, Robin Maximilian Awad, David Escors

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T Cells for the Treatment of Lung Cancer.
Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, David Escors

Life (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Sergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, Diego Alignani, Beatriz Tavira, David Escors

Cancer Lett· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets.
Ester Blanco, Maria Ibañez-Vea, Carlos Hernandez, Lylia Drici, Xabier Martínez de Morentin, David Escors

J Pers Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis